.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Fuji
Covington
Harvard Business School
Argus Health
Medtronic
Cerilliant
Teva
Deloitte
Queensland Health

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203883

« Back to Dashboard
NDA 203883 describes ADENOSINE, which is a drug marketed by West-ward Pharms Int, Luitpold, Sagent Strides, Emcure Pharms Ltd, Wockhardt, Teva Pharms Usa, Fresenius Kabi Usa, Mylan Labs Ltd, Akorn, Gland Pharma Ltd, and Hospira Inc, and is included in seventeen NDAs. It is available from fourteen suppliers. Additional details are available on the ADENOSINE profile page.

The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.

Summary for NDA: 203883

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 203883

Mechanism of ActionAdenosine Receptor Agonists

Suppliers and Packaging for NDA: 203883

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADENOSINE
adenosine
SOLUTION;IV (INFUSION) 203883 ANDA Hospira, Inc. 0409-1932 0409-1932-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1932-01) > 20 mL in 1 VIAL, SINGLE-DOSE
ADENOSINE
adenosine
SOLUTION;IV (INFUSION) 203883 ANDA Hospira, Inc. 0409-1932 0409-1932-02 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1932-02) > 30 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength60MG/20ML (3MG/ML)
Approval Date:Mar 24, 2014TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength90MG/30ML (3MG/ML)
Approval Date:Mar 24, 2014TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Julphar
Merck
Queensland Health
Deloitte
Citi
Cerilliant
Covington
US Army
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot